Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Natural Product (NP) Details

General Information of the NP (ID: NP7376)
Name
Visnagin
Synonyms
Visnagin; 82-57-5; Desmethoxykhellin; Visnagidin; Visnagine; 4-Methoxy-7-methyl-5H-furo[3,2-g]chromen-5-one; 5-Methoxy-2-methylfuranochromone; 4-methoxy-7-methylfuro[3,2-g]chromen-5-one; UNII-P64438MLBW; 4-Methoxy-7-methyl-furo[3,2-g]chromen-5-one; CHEMBL45176; P64438MLBW; CHEBI:10002; 5H-Furo[3,2-g][1]benzopyran-5-one, 4-methoxy-7-methyl-; 5H-FURO(3,2-g)(1)BENZOPYRAN-5-ONE, 4-METHOXY-7-METHYL-; 4-Methoxy-7-methylfuro(3,2-g)chromen-5-one; Desmethoxykhellin; NSC 100593; Visnagidin; Visnagine; 4-Methoxy-7-methyl-5H-furo[3,2-g][1]benzopyran-5-one, 97%; 5-methoxy-2-methylfurano[3,2-g]chromen-4-one; SR-01000765669; EINECS 201-430-3; NSC 100593; BRN 0234955; 4-Methoxy-7-methyl-5H-furo(3,2-g)(1)-benzopyran-5-one; 5H-Furo[3,2-g][1]benzopyran-5-one,4-methoxy-7-methyl-; Spectrum_001227; SpecPlus_000453; Spectrum2_001796; Spectrum3_001340; Spectrum4_001766; Spectrum5_000351; Oprea1_854963; BSPBio_003099; GTPL433; KBioGR_002251; KBioSS_001707; SPECTRUM310041; 5-19-06-00030 (Beilstein Handbook Reference); MLS000697721; DivK1c_006549; SCHEMBL498450; SPBio_001751; MEGxp0_000332; KBio1_001493; KBio2_001707; KBio2_004275; KBio2_006843; KBio3_002319; NZVQLVGOZRELTG-UHFFFAOYSA-; DTXSID50231509; FUK-724; HMS2268P15; ZINC120179; 5H-Furo[3, 4-methoxy-7-methyl-; BBL027492; BDBM50051349; CCG-38444; LMPK13110003; NSC100593; SBB057568; STL372894; AKOS015955735; MCULE-6909437128; NSC-100593; SDCCGMLS-0066603.P001; NCGC00095626-01; NCGC00095626-02; NCGC00178297-01; SMR000112234; VS-08551; DB-056633; FT-0603293; ST50307139; W2039; C09049; L000822; 4-methoxy-7-methylpyrano[3,2-f][1]benzoxol-5-one; Q7936365; SR-01000765669-3; SR-01000765669-4; 4-Methoxy-7-methyl-5H-furo[3,2-g]chromen-5-one #; BRD-K68995359-001-02-8; BRD-K68995359-001-06-9; 4-Methoxy-7-methyl-5H-furo[3,2-g]-1-benzopyran-5-one; NCGC00095626-04!4-methoxy-7-methylfuro[3,2-g]chromen-5-one
    Click to Show/Hide
Species Origin Ammi visnaga ...     Click to Show/Hide
Ammi visnaga
Kingdom: Viridiplantae
Phylum: Streptophyta
Class: Magnoliopsida
Order: Apiales
Family: Apiaceae
Genus: Ammi
Species: Ammi visnaga
Disease Acute pancreatitis [ICD-11: DC31] Investigative [1]
Structure
Click to Download Mol
2D MOL

3D MOL

    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
C13H10O4
PubChem CID
6716
Canonical SMILES
CC1=CC(=O)C2=C(O1)C=C3C(=C2OC)C=CO3
InChI
1S/C13H10O4/c1-7-5-9(14)12-11(17-7)6-10-8(3-4-16-10)13(12)15-2/h3-6H,1-2H3
InChIKey
NZVQLVGOZRELTG-UHFFFAOYSA-N
CAS Number
CAS 82-57-5
ChEBI ID
CHEBI:10002
Herb ID
HBIN048033
SymMap ID
SMIT06014
TCMSP ID
MOL004029
TTD Drug ID
D0MH4R
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Adverse Effect can be Decreased by This NP
          Doxorubicin      Solid tumour/cancer     Click to Show/Hide the Molecular Data of This Drug
                 Decreasing Adverse Drug Reaction     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Molecule(s)
                    Regulation
Down-regulation Expression MDH2  Molecule Info 
Pathway MAP
                    In-vitro Model DU145 CVCL_0105 Prostate carcinoma Homo sapiens
LNCaP CVCL_0395 Prostate carcinoma Homo sapiens
MCF-7 CVCL_0031 Invasive breast carcinoma Homo sapiens
MDA-MB-231 CVCL_0062 Breast adenocarcinoma Homo sapiens
                    In-vivo Model Zebrafish and male C57BL/6 mice were used in this study.
                    Experimental
                    Result(s)
Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.
Target and Pathway
Target(s) Adenosine A2b receptor (ADORA2B)  Molecule Info  [3]
Adenosine A3 receptor (ADORA3)  Molecule Info  [3]
KEGG Pathway Rap1 signaling pathway Click to Show/Hide
2 Calcium signaling pathway
3 Neuroactive ligand-receptor interaction
4 Vascular smooth muscle contraction
5 Alcoholism
NetPath Pathway TGF_beta_Receptor Signaling Pathway Click to Show/Hide
2 TCR Signaling Pathway
Pathwhiz Pathway Intracellular Signalling Through Adenosine Receptor A2b and Adenosine Click to Show/Hide
Pathway Interaction Database C-MYB transcription factor network Click to Show/Hide
Reactome Adenosine P1 receptors Click to Show/Hide
2 G alpha (s) signalling events
3 Surfactant metabolism
4 G alpha (i) signalling events
WikiPathways Nucleotide GPCRs Click to Show/Hide
2 GPCRs, Class A Rhodopsin-like
3 GPCR ligand binding
4 GPCR downstream signaling
5 GPCRs, Other
References
Reference 1 Visnagin attenuates acute pancreatitis via Nrf2/NFKappaB pathway and abrogates associated multiple organ dysfunction. Biomed Pharmacother. 2019 Apr;112:108629.
Reference 2 Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase. Sci Transl Med. 2014 Dec 10;6(266):266ra170.
Reference 3 Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists. J Med Chem. 1996 Jun 7;39(12):2293-301.
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China